Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Anaerobe. 2024 Oct;89:102898. doi: 10.1016/j.anaerobe.2024.102898. Epub 2024 Aug 13.
Bacteremia with anaerobic bacteria is generally a marker of severe prognosis. However, population-based data is lacking. Our aim was to describe the epidemiology and the 30-day mortality rate of anaerobic bacteremia in a Danish population-based setting.
In this population-based cohort study, all first-time episodes of anaerobic bacteremia from the North Denmark Bacteremia Research Database during 1994-2019 were identified. Information on comorbidities, discharge diagnoses, and mortality was retrieved. 30-day mortality rates were calculated and a multivariate logistic regression analysis to identify risk factors for death was performed.
1750 episodes with anaerobic bacteremia were identified, corresponding to an incidence rate of 12.5 per 100,000 inhabitants (increasing from 11.2 in 1994-2014 to 17.7 in 2015-2019). Of these episodes, a third were polymicrobial, and the majority (70 %) of patients had one or more comorbid conditions. Abdominal infection was the source of bacteremia in 61 % of patients, while it was unknown for 15 %. The most frequently isolated genera were Bacteroides (45 %), Clostridium (20 %) and Fusobacterium (6 %). The overall crude 30-day mortality rate was 27 %, but rates were even higher for patients of high age, with liver disease, and solid tumors. The odds ratio (OR) for 30-day mortality was 1.32 for Clostridium species, and 1.27 for polymicrobial bacteremia with aerobic bacteria.
The incidence rate of anaerobic bacteremia increased, and the 30-day mortality rate remained high during the study period. Multiple factors influence 30-day mortality rates, including high age, liver disease, solid tumor, polymicrobial bacteremia, and bacteremia with Clostridium species.
厌氧菌引起的菌血症通常是预后严重的标志。然而,目前缺乏基于人群的数据。本研究旨在描述丹麦人群中厌氧菌菌血症的流行病学和 30 天死亡率。
在这项基于人群的队列研究中,从 1994 年至 2019 年,从丹麦北方菌血症研究数据库中确定了所有首次发生的厌氧菌菌血症病例。检索了合并症、出院诊断和死亡率的信息。计算了 30 天死亡率,并进行了多变量逻辑回归分析以确定死亡的危险因素。
共确定了 1750 例厌氧菌菌血症病例,发病率为每 100000 人 12.5 例(从 1994 年至 2014 年的 11.2 例增加到 2015 年至 2019 年的 17.7 例)。这些病例中有三分之一为混合感染,大多数(70%)患者有 1 种或多种合并症。腹部感染是菌血症的来源,占 61%,15%的菌血症来源不明。最常分离到的菌属是拟杆菌属(45%)、梭菌属(20%)和梭杆菌属(6%)。总体 30 天死亡率为 27%,但年龄较大、患有肝病和实体瘤的患者死亡率更高。30 天死亡率的比值比(OR)为梭菌属 1.32,需氧菌混合感染的 OR 为 1.27。
在研究期间,厌氧菌菌血症的发病率增加,30 天死亡率仍然很高。多种因素影响 30 天死亡率,包括年龄较大、肝病、实体瘤、混合感染和梭菌属感染。